Medazepam

Medazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. MEDAZEPAM is a small molecule drug with a maximum clinical trial phase of IV and is indicated in anxiety. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines and Schedule IV controlled substances. Its therapeutic use is listed as antianxiety drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pamnace, Nobrium, Resmit, Rudotel and Enobrin. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 4041.

CAS No 2898-12-6
Molecular Formula C16H15ClN2
Molecular Weight 270.75 g/mol
Synonyms 7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine

Frequently Asked Questions